These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15470339)

  • 1. Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients.
    Hermann M; Asberg A; Christensen H; Holdaas H; Hartmann A; Reubsaet JL
    Clin Pharmacol Ther; 2004 Oct; 76(4):388-91. PubMed ID: 15470339
    [No Abstract]   [Full Text] [Related]  

  • 2. Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients.
    Hermann M; Asberg A; Christensen H; Reubsaet JL; Holdaas H; Hartmann A
    Eur J Clin Pharmacol; 2005 Mar; 61(1):59-62. PubMed ID: 15711834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients.
    Asberg A; Hartmann A; Fjeldså E; Bergan S; Holdaas H
    Am J Transplant; 2001 Nov; 1(4):382-6. PubMed ID: 12099384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase.
    Whitfield LR; Stern RH; Sedman AJ; Abel R; Gibson DM
    Eur J Drug Metab Pharmacokinet; 2000; 25(2):97-101. PubMed ID: 11112089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved HPLC method with the aid of a chemometric protocol: simultaneous determination of atorvastatin and its metabolites in plasma.
    Crevar-Sakač M; Vujić Z; Brborić J; Kuntić V; Uskoković-Marković S
    Molecules; 2013 Feb; 18(3):2469-82. PubMed ID: 23439563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins: is it safe and effective to use generic "equivalents"?
    Jackevicius CA; Tu JV; Krumholz HM
    Can J Cardiol; 2013 Apr; 29(4):408-10. PubMed ID: 23062664
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of food on the bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
    Chung M; Calcagni A; Glue P; Bramson C
    J Clin Pharmacol; 2006 Oct; 46(10):1212-6. PubMed ID: 16988211
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
    Taylor PJ; Kubler PA; Lynch SV; Allen J; Butler M; Pillans PI
    Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
    Maltz HC; Balog DL; Cheigh JS
    Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin.
    Ando H; Tsuruoka S; Yanagihara H; Sugimoto K; Miyata M; Yamazoe Y; Takamura T; Kaneko S; Fujimura A
    Br J Clin Pharmacol; 2005 Nov; 60(5):494-7. PubMed ID: 16236039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and bioequivalence testing of atorvastatin formulations in healthy male volunteers.
    Mendoza L; Hajdúch M; Plausinaitis R; Platílová V; Emritte N; Svoboda M
    Pharmazie; 2006 Sep; 61(9):805-6. PubMed ID: 17020163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of atorvastatin.
    Lennernäs H
    Clin Pharmacokinet; 2003; 42(13):1141-60. PubMed ID: 14531725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats.
    Dong J; Yu X; Wang L; Sun YB; Chen XJ; Wang GJ
    Acta Pharmacol Sin; 2008 Oct; 29(10):1247-52. PubMed ID: 18817631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin--a new lipid-lowering drug.
    Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394
    [No Abstract]   [Full Text] [Related]  

  • 18. BSA nanoparticle loaded atorvastatin calcium--a new facet for an old drug.
    Sripriyalakshmi S; Anjali CH; George PD; Rajith B; Ravindran A
    PLoS One; 2014; 9(2):e86317. PubMed ID: 24498272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy.
    Hermann M; Bogsrud MP; Molden E; Asberg A; Mohebi BU; Ose L; Retterstøl K
    Clin Pharmacol Ther; 2006 Jun; 79(6):532-9. PubMed ID: 16765141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of pravastatin and cyclosporin in transplant patients.
    Christians U
    Clin Pharmacokinet; 1997 Feb; 32(2):173-4. PubMed ID: 9068930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.